Stem cell IV therapy, the intravenous infusion of cell-based products, is often promoted for inflammation, fatigue, recovery, and healthy aging. It is also one of the most closely scrutinized areas of regenerative medicine. Placing any biologic product directly into the bloodstream carries real risks, and outside of a few established uses, the evidence for benefit is still emerging. Patients in Beverly Hills and Los Angeles who are curious about stem cell infusions deserve accurate information before making any decision.
Dr. David Nazarian’s view of intravenous therapies is shaped by years of hospital medicine. As a hospitalist at Huntington Memorial Hospital and Arcadia Methodist Hospital, he cared for patients with complex medical conditions requiring inpatient management, work that demands close attention to infusion safety, infection, and clotting risk. He completed his internal medicine residency at Huntington Memorial Hospital, a USC teaching affiliate, and is a diplomate of the American Board of Internal Medicine.
“Putting any biologic product into the bloodstream is a serious medical decision. I want every patient to understand exactly what they would be receiving, how it is regulated, and what the evidence does and does not show.” — Dr. Nazarian
I have been seeing Dr. Nazarian for more than 5 years now and I am grateful for all the care he has given me. He is one of the most caring and professional doctors I have ever seen and he genuinely cares about all his patients. I will continue to entrust him with my health care for many years to come. Thanks Dr. Nazarian – Andrew
What Stem Cell IV Therapy Is and How It Is Regulated
Stem cell infusions generally use one of two sources. Some use donor cells, often mesenchymal stromal cells grown in a laboratory from umbilical cord tissue. Others use a patient’s own cells, typically fat-derived preparations. Both are regulated closely by the FDA:
- Established Intravenous Uses: Blood-forming stem cell transplants for blood cancers and certain blood disorders are established and performed in specialized transplant centers.
- Narrow FDA Approvals: A mesenchymal stromal cell product received FDA approval in December 2024 for a specific, serious transplant complication in children.
- Laboratory-Grown and Processed Cells: Cells that are expanded in culture or significantly processed are regulated as drugs or biologics and require FDA approval or an FDA-reviewed clinical trial.
- Fat-Derived Preparations: A 2024 federal appeals ruling held that a processed fat-derived cell preparation is a drug subject to FDA oversight, even when it comes from the patient’s own body.
The FDA has stated that regenerative medicine products have not been approved to treat chronic pain, fatigue, neurological disorders, or heart and lung diseases. Its consumer information on regenerative medicine describes reported harms from unapproved products, including life-threatening blood infections, immune reactions, and tumor formation.
Researchers are studying intravenous cell therapies for conditions such as acute lung injury, multiple sclerosis, heart failure, and age-related frailty. Results so far are mixed and early, and these remain investigational uses. More context is available on our stem cell therapy page.
Common Concerns That Lead Patients to Ask About Stem Cell Infusions
Patients often ask about stem cell IV therapy because of persistent fatigue, lingering symptoms after an infection, chronic inflammation, slower recovery, or a desire to age well. These concerns are valid, and they usually have identifiable, treatable contributors. Thyroid disease, anemia and iron deficiency, vitamin deficiencies, sleep apnea, hormonal changes, depression, and medication side effects are all common causes of fatigue that a thorough evaluation can uncover.
Dr. Nazarian’s internal medicine approach begins there, with a detailed history, examination, and targeted laboratory blood work. For patients focused on long-term health, an executive physical and our longevity medicine services offer structured, evidence-based ways to reduce risk and improve how you feel. When a documented deficiency is present, treatments such as iron infusions have clear medical indications.
Understanding the Risks of Intravenous Cell Products
Intravenous cell products carry risks that are different from nutrient infusions. These include infusion reactions, infection from contaminated products, immune reactions to donor cells, blood clots, cells lodging in the lungs, and uncertain long-term effects. The FDA has also described cases where products marketed as stem cells were contaminated or not tested for infectious diseases. If you have received any infusion and develop fever, chills, shortness of breath, chest pain, or confusion, call 911 or go to the nearest emergency room.
What to Expect During Your Consultation
Your visit in Beverly Hills begins with a complete medical evaluation focused on your symptoms and goals. Dr. Nazarian will explain which treatments have strong evidence for your situation and, if you are interested in cell-based therapy, review the specific product, its regulatory status, and the published human data. He can also help you identify legitimate clinical trials, including those at academic medical centers, and explain what participation involves.
FAQ About Stem Cell IV Therapy at My Concierge MD
-
Only for narrow, serious indications, such as blood-forming stem cell transplants and one cell product for a specific transplant complication in children. It is not approved for fatigue, inflammation, anti-aging, or general wellness.
-
Not necessarily. A 2024 federal appeals ruling held that a processed fat-derived preparation is a drug subject to FDA oversight, and processing your own cells still carries risks such as contamination.
-
Laboratory and animal studies are promising, but these effects have not been established in people. Research in humans is ongoing.
-
Risks include infusion reactions, infection, immune reactions, blood clots, and unknown long-term effects. The FDA has received reports of serious harm linked to unapproved products.
-
Nutrient infusions deliver vitamins, minerals, or fluids, while stem cell infusions deliver biologic cell products with a different risk profile and regulatory framework. See our IV therapy page.
-
Dr. Nazarian can review trials relevant to your health, explain eligibility, and help you evaluate whether a program is legitimate. Our stem cell therapy page lists key questions to ask.
Why Choose Dr. Nazarian for Stem Cell IV Guidance
Choosing My Concierge MD means opting for a patient-centered approach to health. Under the leadership of Dr. David Nazarian, a board-certified physician recognized for excellence in concierge medicine, we prioritize your well-being through:
- Hospital Medicine Experience: Infusion safety, infection, and clotting risks are well understood.
- Root-Cause Evaluation: Fatigue and inflammation are investigated before any therapy is considered.
- Regulatory Clarity: Clear answers on the FDA status of any product.
- Trial Navigation: Help evaluating legitimate research opportunities.
Let us partner with you on your journey to enhanced health and longevity through innovative treatments tailored to your unique needs. Contact our award-winning team today.
About UsSchedule a Stem Cell IV Therapy Consultation in Beverly Hills
If you are curious about stem cell infusions, an independent physician review is the safest place to begin. Dr. Nazarian welcomes patients from Beverly Hills and across Los Angeles who want evidence-based answers and a plan built around their health. Schedule your consultation today and take the first step toward enhanced well-being.
Medically reviewed by David Nazarian, MD on